Harry C. Schouten

High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia

Bob Löwenberg, Gert J. Ossenkoppele, Wim van Putten et al. · New England Journal of Medicine · 2009 · 822 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Long-Term Survival and Late Deaths after Allogeneic Bone Marrow Transplantation

Gèrard Socié, Judith V. Stone, John R. Wingard et al. · New England Journal of Medicine · 1999 · 701 citations · Full text

Public Health, Biostatistics, Hematology +12

High-Dose Therapy Improves Progression-Free Survival and Survival in Relapsed Follicular Non-Hodgkin’s Lymphoma: Results From the Randomized European CUP Trial

Harry C. Schouten, Wendi Qian, Stein Kvaløy et al. · Journal of Clinical Oncology · 2003 · 479 citations

Medicine, Hematology, Oncology +15

Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?

Jan J. Cornelissen, Wim L.J. van Putten, Leo F. Verdonck et al. · Blood · 2007 · 470 citations · Full text

Medicine, Hematology, Oncology +17

Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs

Robyn M. Emanuel, Amylou C. Dueck, Holly L. Geyer et al. · Journal of Clinical Oncology · 2012 · 458 citations · Full text

Medicine, Internal Medicine, Oncology +17